Loading clinical trials...
Loading clinical trials...
The purpose of the study is to prospectively assess longitudinal changes in proteolipid protein 1 (PLP1) protein, disease-related biomarkers in cerebral spinal fluid (CSF) and blood, neuroimaging para...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Ionis Pharmaceuticals, Inc.
NCT03333200 · MLD, Krabbe Disease, and more
NCT03047369 · Leukodystrophy, White Matter Disease, and more
NCT02254863 · Adrenoleukodystrophy, Batten Disease, and more
NCT01391637 · Pelizaeus-Merzbacher Disease, PMD
Ionis Investigative Site
Philadelphia, Pennsylvania
Ionis Investigative Site
Clermont-Ferrand
Ionis Investigative Site
Le Kremlin-Bicêtre
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions